| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adapted hepatitis C virus clone infects innate immunity-deficient mouse hepatocytes with minimal human HCV entry factors
|
Sheldon, Julie Ann
|
|
|
7 |
5 |
p.
|
article
|
| 2 |
AI-Cirrhosis-ECG (ACE) score for predicting decompensation and liver outcomes
|
Ahn, Joseph C.
|
|
|
7 |
5 |
p.
|
article
|
| 3 |
A novel in vitro system for simultaneous infections with hepatitis B, C, D and E viruses
|
Fouillé, Roxanne
|
|
|
7 |
5 |
p.
|
article
|
| 4 |
Associations between fruit and vegetable consumption and HCC occurrence in patients with cirrhosis
|
Manneville, Florian
|
|
|
7 |
5 |
p.
|
article
|
| 5 |
Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response
|
Fink, Douglas L.
|
|
|
7 |
5 |
p.
|
article
|
| 6 |
Cirrhosis epidemiology in Denmark 1998–2022, and 2030 forecast
|
Kornerup, Linda Skibsted
|
|
|
7 |
5 |
p.
|
article
|
| 7 |
Comment on “Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort”
|
Han, Ji-Eun
|
|
|
7 |
5 |
p.
|
article
|
| 8 |
Contents
|
|
|
|
7 |
5 |
p.
|
article
|
| 9 |
Copyright and information
|
|
|
|
7 |
5 |
p.
|
article
|
| 10 |
Corrigendum to ‘Cholangiocarcinoma across England: Temporal changes in incidence, survival and routes to diagnosis by region and level of socioeconomic deprivation’ [JHEP Reports 6 (2024) 100983]
|
Tataru, Daniela
|
|
|
7 |
5 |
p.
|
article
|
| 11 |
Deep learning empowered gadolinium-free contrast-enhanced abbreviated MRI for diagnosing hepatocellular carcinoma
|
Zhang, Yunfei
|
|
|
7 |
5 |
p.
|
article
|
| 12 |
Dynamic imaging of macrophages in MASLD: A major interest in insulin resistance and outside the liver
|
Lanthier, Nicolas
|
|
|
7 |
5 |
p.
|
article
|
| 13 |
Editorial Board page
|
|
|
|
7 |
5 |
p.
|
article
|
| 14 |
Evolving epidemiology of HCC in Spain
|
Sala, Margarita
|
|
|
7 |
5 |
p.
|
article
|
| 15 |
Hepatic immune environment differences among common mouse strains in models of MASH and liver cancer
|
Huang, Patrick
|
|
|
7 |
5 |
p.
|
article
|
| 16 |
Identification of a cancer stem cell-like subpopulation that promotes HCC metastasis
|
Yang, Chunyuan
|
|
|
7 |
5 |
p.
|
article
|
| 17 |
Identifying emergency presentations of chronic liver disease using routinely collected administrative hospital data
|
King, Jessica
|
|
|
7 |
5 |
p.
|
article
|
| 18 |
Liver fibrosis progression analyzed with AI predicts renal decline
|
Sun, Dan-Qin
|
|
|
7 |
5 |
p.
|
article
|
| 19 |
Macrophage ATG16L1 promotes liver regeneration after partial hepatectomy
|
Zhan, Xinyu
|
|
|
7 |
5 |
p.
|
article
|
| 20 |
Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis
|
Schulze, Kornelius
|
|
|
7 |
5 |
p.
|
article
|
| 21 |
Multicenter evaluation of abbreviated MRI and ultrasound for detecting early-stage hepatocellular carcinoma
|
Seif El Dahan, Karim
|
|
|
7 |
5 |
p.
|
article
|
| 22 |
PLOD1 promotes the malignancy of hepatocellular carcinoma by facilitating the NF-κB/IL-6/STAT3-dependent TCA cycle
|
Zhang, Chengfei
|
|
|
7 |
5 |
p.
|
article
|
| 23 |
Prevalence of Rocahepevirus ratti (rat hepatitis E virus) in humans and rats in China
|
Cui, Xiuji
|
|
|
7 |
5 |
p.
|
article
|
| 24 |
Protective role of physical activity against HCC risk in type 2 diabetes: Evidence and public health perspectives
|
Shi, Haiquan
|
|
|
7 |
5 |
p.
|
article
|
| 25 |
Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
|
Moolla, Ahmad
|
|
|
7 |
5 |
p.
|
article
|
| 26 |
Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival
|
Ronca, Vincenzo
|
|
|
7 |
5 |
p.
|
article
|
| 27 |
Reply to: “A comment on ”
|
Kim, Mi Na
|
|
|
7 |
5 |
p.
|
article
|
| 28 |
Reply to: “Comment on “Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort””
|
Lee, Jisoo
|
|
|
7 |
5 |
p.
|
article
|
| 29 |
Reply to: “Dynamic imaging of macrophages in MASLD: A major interest in insulin resistance and outside the liver”
|
Liu, Yongjian
|
|
|
7 |
5 |
p.
|
article
|
| 30 |
Reply to: “Trans-splenic anterograde coil assisted transvenous obliteration vs. retrograde transvenous obliteration: Are we heading the right way?”
|
Senzolo, Marco
|
|
|
7 |
5 |
p.
|
article
|
| 31 |
Rifaximin in the spotlight: Are we ready to target the microbiome?
|
Artru, Florent
|
|
|
7 |
5 |
p.
|
article
|
| 32 |
Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma
|
Tsakiridis, Evangelia E.
|
|
|
7 |
5 |
p.
|
article
|
| 33 |
Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC
|
Kohya, Risako
|
|
|
7 |
5 |
p.
|
article
|
| 34 |
Serum proteomics of adults with acute liver failure provides mechanistic insights and attractive prognostic biomarkers
|
Remih, Katharina
|
|
|
7 |
5 |
p.
|
article
|
| 35 |
Thyroid dysfunction in MASLD: Results of a nationwide study
|
Yuan, Shuai
|
|
|
7 |
5 |
p.
|
article
|
| 36 |
Trans-splenic anterograde coil assisted transvenous obliteration vs. retrograde transvenous obliteration: Are we heading the right way?
|
Biswas, Sagnik
|
|
|
7 |
5 |
p.
|
article
|
Journal description